US Stock MarketDetailed Quotes
NBIX Neurocrine Biosciences
- 125.650
- +0.650+0.52%
Close Nov 22 16:00 ET
- 125.650
- 0.0000.00%
Post 20:01 ET
12.72BMarket Cap33.51P/E (TTM)
127.000High124.380Low1.21MVolume125.180Open125.000Pre Close151.61MTurnover1.21%Turnover Ratio50.87P/E (Static)101.25MShares157.98052wk High4.68P/B12.58BFloat Cap110.52052wk Low--Dividend TTM100.09MShs Float157.980Historical High--Div YieldTTM2.10%Amplitude1.940Historical Low125.631Avg Price1Lot Size
Neurocrine Biosciences Key Stats
EPS
According to the latest financial report of Neurocrine Biosciences, the latest earnings per share (TTM) for the company is 1.24. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Neurocrine Biosciences's free cash flow? The latest report shows it as 149.90M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Neurocrine Biosciences shows that the company's current ratio is 4.37, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Neurocrine Biosciences, the quick ratio is 3.98, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Neurocrine Biosciences? The latest ROE figure is 4.97%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Neurocrine Biosciences, the total asset return on investment (ROA) is 3.80%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Neurocrine Biosciences's latest financial report to see how their gross margin is doing - currently at 98.71%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Neurocrine Biosciences, the net profit margin is 20.86%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data